Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Provectus Biopharmaceuticals Inc (PVCT)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 400,980,000
Market Cap: N/A
Last Volume: 9,148,849 Avg Vol: 4,224,492
52 Week Range: $5.22 - $5.22
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Provectus Biopharmaceuticals is a clinical-stage biotechnology company developing a new class of drugs for oncology, hematology, and dermatology based on an entire, wholly-owned, family of chemical small molecules calledhalogenated xanthenes. Intratumoral (intralesional) PV-10®, the first small molecule autolytic immunotherapy, which can induce immunogenic cell death, is undergoing clinical study for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, and preclinical study for pediatric solid tumor cancers and blood cancers. Topical PH-10® is undergoing clinical study for inflammatory dermatoses.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 137
  Page 2 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Scott Timothy Phd President   •       •      –    2014-12-30 4 OE $0.64 $80,871 I/I 126,361 426,361     -
   Scott Timothy Phd President   •       •      –    2014-10-29 4 OE $0.64 $62,000 D/D 96,875 1,521,845     -
   Culpepper Peter R CFO & COO   •       –      –    2014-06-28 4 OE $1.25 $125,000 D/D 100,000 1,112,332     -
   Scott Timothy Phd President   •       –      –    2014-05-19 4 OE $0.95 $23,750 D/D 25,000 1,424,970     -
   Wachter Eric Phd Chief Technology Officer   •       –      –    2014-03-20 4 OE $0.75 $592,436 D/D 639,248 6,032,484     -
   Culpepper Peter R CFO & COO   •       –      –    2014-02-26 4 OE $1.10 $133,100 I/I 121,000 121,000     -
   Culpepper Peter R CFO & COO   •       –      –    2014-02-26 4 OE $1.10 $75,486 D/D 68,624 1,012,332     -
   Scott Timothy Phd President   •       –      –    2014-02-26 4 OE $1.10 $330,000 I/I 300,000 300,000     -
   Koe Jan Director   –       •      –    2013-09-20 4 B $0.00 $0 D/D 100,000 586,300 2.31     -
   Dees H Craig Chief Executive Officer   •       •      –    2013-05-29 4 OE $0.32 $21,000 D/D 43,750 1,497,859     -
   Culpepper Peter R CFO, COO   •       –      –    2012-12-03 4 B $0.00 $0 D/D 133,333 943,708 2.66     -
   Culpepper Peter R CFO, COO   •       –      –    2012-11-16 4 B $0.00 $0 D/D 133,333 810,375 2.66     -
   Wachter Eric Phd Chief Technology Officer   •       –      –    2012-11-16 4 B $0.00 $0 D/D 666,666 5,393,236 2.66     -
   Koe Jan Director   –       •      –    2012-05-14 3 IO $0.00 $0 I/I 0 150,000     -
   Koe Jan Director   –       •      –    2012-05-14 3 IO $0.00 $0 D/D 0 486,300     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-12-05 4 OE $0.75 $75,000 D/D 100,000 4,726,570     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-12-01 4 OE $0.93 $93,000 D/D 100,000 4,626,570     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-11-23 4 OE $0.93 $93,000 D/D 100,000 4,526,570     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-10-19 4 OE $0.93 $93,000 D/D 100,000 4,426,570     -
   Scott Timothy Phd President   •       •      –    2011-10-06 4 OE $0.32 $39,000 D/D 100,000 1,399,970     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-09-07 4 OE $0.93 $93,000 D/D 100,000 4,326,570     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-07-29 4 OE $1.00 $100,000 D/D 100,000 4,226,570     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-05-03 4 OE $1.00 $100,000 D/D 100,000 4,126,570     -
   Culpepper Peter R Chief Financial Officer   •       –      –    2011-05-03 4 OE $0.75 $100,000 D/D 133,333 677,042     -
   Wachter Eric Phd Vice President Pharmaceuticals   •       •      –    2011-04-20 4 OE $1.00 $100,000 D/D 100,000 4,026,570     -
  137 Records found
  1  2  3  4  5  6   
  Page 2 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us